The SHINE Trial
SHINE was a large randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating engineered mesoporous silica particles in individuals with overweight or obesity and prediabetes or newly diagnosed type 2 diabetes. The study was published in eClinicalMedicine, a Lancet Discovery Science journal.
- PARTICIPANTS
- 318
- WEEKS
- 12
- CLINICAL SITES
- 27
- PUBLICATION
- 2026
Baek J, et al. Effect of Engineered Mesoporous Silica Particles with Tailored Pore Size on Glycaemic Control in Individuals with Prediabetes or Type 2 Diabetes: SHINE Trial. eClinicalMedicine. 2026;97:104042.
Explore the clinical evidence









